Prostatic Hyperplasia: all 803 studies

Page 8 of 9. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Transurethral Ventral Wall of Urethra-preserving Enucleation of ProstateStatus unknownNCT01073241Not applicable
• MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic UseCompletedNCT01050465Not applicable
• TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia ManagementCompletedNCT01043588Not applicable
• Clinical Study to Assess the Influence of a Saw Palmetto Preparation in Patients With Benign Prostatic Hyperplasia (BPH) and Sexual DysfunctionsStatus unknownNCT01021267Phase 4
• Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002664Phase 3
• MCS in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002417Phase 2/3
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract SymptomsCompletedNCT01002274Phase 3
• Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)CompletedNCT01002222Phase 3
• Extension Study of GI198745 to Treat Benign Prostatic HyperplasiaCompletedNCT00969072Phase 2
• Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mgStatus unknownNCT00954889Not applicable
• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018CompletedNCT00945490Phase 3
• Benign Prostatic Hyperplasia in TaiwanCompletedNCT00941343Not applicable
• Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)CompletedNCT00922506Phase 4
• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)CompletedNCT00918983Phase 3
• Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00918034Phase 2
• Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic HyperplasiaCompletedNCT00908427Not applicable
• Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short DurationCompletedNCT00890851Not applicable
• MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® TreatmentCompletedNCT00885027
• Effect of Dutasteride on HIF-1alpha and VEGF in the ProstateCompletedNCT00880672Phase 4
• Efficacy Study of HoLEP and TURP on LUTS Secondary to BPHCompletedNCT00877669Phase 2
• Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate HyperplasiaCompletedNCT00861588Not applicable
• Evaluation of Symptom-specific Goal AchievementCompletedNCT00836823Phase 4
• Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic ObstructionCompletedNCT00827814Phase 4
• Prostate Mechanical Imager (PMI) Clinical Bridging StudyCompletedNCT00822952
• A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031CompletedNCT00814736Phase 1
• Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw PalmettoCompletedNCT00797394Phase 2
• Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedNCT00771394Phase 4
• Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)CompletedNCT00759135Phase 2
• Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)TerminatedNCT00743184Phase 2
• Effects of Chronic Use of Doxazosin in Men With Benign Prostatic HyperplasiaCompletedNCT00730418Not applicable
• Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00709488Phase 1
• A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary HesitancyCompletedNCT00700505Not applicable
• A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to AvodartStatus unknownNCT00690950Phase 4
• The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic HyperplasiaWithdrawnNCT00687388Phase 4
• Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha BlockerCompletedNCT00680680Not applicable
• Temperature Mapping of the Prostate With the Wallterm™ SystemCompletedNCT00662350
• Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic HyperplasiaCompletedNCT00657839Phase 2
• A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)TerminatedNCT00651807Phase 2
• Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate EnlargementCompletedNCT00648323Phase 4
• A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With DoxazosinCompletedNCT00645034Phase 2
• Once Daily Given Alfuzosin in the Treatment of BPHCompletedNCT00637715Phase 4
• Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice WorkflowCompletedNCT00634608Not applicable
• A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.CompletedNCT00609596Phase 1
• Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate HyperplasiaCompletedNCT00593593
• On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)WithdrawnNCT00564460Phase 3
• Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow upTerminatedNCT00563654Not applicable
• Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow upTerminatedNCT00563485Not applicable
• Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsCompletedNCT00547625Phase 2
• The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate ScoreCompletedNCT00540891Phase 3
• A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted StateCompletedNCT00537654Phase 1
• PVP Compared to TURP for the Treatment of Benign Hyperplasia of the ProstateCompletedNCT00527371Not applicable
• Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITSCompletedNCT00517179Not applicable
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
• MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic HyperplasiaTerminatedNCT00501371Phase 3
• The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese PatientsStatus unknownNCT00497939Not applicable
• SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00486785Phase 4
• One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH PatientsCompletedNCT00472251
• Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human ProstateStatus unknownNCT00468026Phase 1
• Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.CompletedNCT00457457Phase 2
• ALF-STONE: Alfuzosin in Uretheric StonesTerminatedNCT00454402Phase 3
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic HyperplasiaTerminatedNCT00435448Phase 3
• Male Sexual Health Questionnaire (MSHQ) - Sexual Function StudyCompletedNCT00427882Phase 4
• PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate CarcinomaCompletedNCT00427817
• The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the ProstateCompletedNCT00427219Phase 2
• Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without CatheterTerminatedNCT00421421Phase 4
• Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaCompletedNCT00416390Not applicable
• Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic HyperplasiaCompletedNCT00409357Phase 2
• Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract SymptomsCompletedNCT00408954Phase 2
• Urokinase Plasminogen Activator System in Benign Prostatic HyperplasiaCompletedNCT00407329
• Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00401661Phase 4
• Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate CarcinomaStatus unknownNCT00400894
• Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic HyperplasiaCompletedNCT00399464Phase 3
• Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)CompletedNCT00382356Not applicable
• Study of the Effects of Pomegranate Tablets on Enlarged ProstatesStatus unknownNCT00381108Phase 1
• A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.CompletedNCT00379067Phase 4
• Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate CancerCompletedNCT00375765Phase 4
• A Prospective Evaluation of the GreenLight Model 120 LaserCompletedNCT00364585Phase 4
• Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPHCompletedNCT00359905Phase 3
• Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPHCompletedNCT00347061Phase 3
• Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASISCompletedNCT00316732
• ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHCompletedNCT00290030Phase 3
• ALF-ONE : ALFuzosin ONcE DailyCompletedNCT00280605Phase 4
• Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)Status unknownNCT00274417Not applicable
• Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)CompletedNCT00256399Not applicable
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic HyperplasiaTerminatedNCT00237536Phase 2
• Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)CompletedNCT00199550Phase 4
• Questioning Patients About Adverse Medical EventsCompletedNCT00187616
• Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the ProstateTerminatedNCT00169767
• Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)CompletedNCT00169585Phase 3
• Laser Prostatectomy Database and RegistryActive, not recruitingNCT00159406
• Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT00143221Phase 4
• Kinetics of the Finasteride Prostate Induced ApoptosisStatus unknownNCT00130767Phase 4
• A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)CompletedNCT00127179Phase 3
• Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)TerminatedNCT00116571Phase 2
• Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General PracticeCompletedNCT00111592Not applicable
• Dose Escalation Study With QLT0074 for Benign Prostatic HyperplasiaCompletedNCT00077012Phase 1/2
• Minimally Invasive Surgical Therapy for BPHTerminatedNCT00064649Phase 3
• Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) LevelsCompletedNCT00062790Phase 4
• A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).Status unknownNCT00044226Phase 2
• Saw Palmetto Extract in Benign Prostatic HyperplasiaCompletedNCT00037154Phase 3

← Prostatic Hyperplasia overview